A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
Clinical trial NCT07409272 · RECRUITING
Trial details
- NCT number
- NCT07409272
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-17
- Primary completion
- 2029-08-31
- Enrollment
- 614
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.